Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R Lassen

Showing results (11-20 of 135) with videos related to

Pageof 14
Sort By:
Current Opinion in Pulmonary Medicine|July 1, 1996
Low molecular weight heparin for the prevention of deep vein thrombosis following orthopedic surgeryM R Lassen, L C Borris
Ugeskrift for Laeger|December 7, 1992
[Tinzaparin, a low molecular weight heparin]L C Borris, M R Lassen
Orthopedics|May 16, 2014
Managing the risk of thrombosis in the perioperative period in patients undergoing orthopedic and trauma surgery with low-molecular-weight heparin: enoxaparinM R Lassen, L C Borris
Haemostasis|March 1, 1993
Venography in deep venous thrombosis: postoperative screening of patients in prophylaxis studiesL C Borris, M R Lassen
Orthopedics|February 1, 1997
Managing the risk of thrombosis in the perioperative period in patients undergoing orthopedic and trauma surgery with low-molecular-weight heparin: enoxaparinM R Lassen, L C Borris
Drugs|January 1, 1996
Thromboprophylaxis with low molecular weight heparin after major orthopaedic surgery is cost effectiveL C Borris, M R Lassen
Seminars in Thrombosis and Hemostasis|January 1, 1993
Venography used for deep vein thrombosis screening of asymptomatic patients undergoing total hip replacementL C Borris, M R Lassen
Archives of Internal Medicine|June 11, 2003
Duration of prophylaxis against venous thromboembolism with fondaparinux after hip fracture surgery: a multicenter, randomized, placebo-controlled, double-blind studyBengt I Eriksson, Michael R Lassen,
The European Journal of Surgery. Supplement. : = Acta Chirurgica. Supplement|January 1, 1994
Clinical profile of enoxaparin in a high-risk situationM R Lassen, L C Borris
Drug Safety|January 1, 1995
A comparative review of the adverse effect profiles of heparins and heparinoidsL C Borris, M R Lassen
Pageof 14

Showing results (11-20 of 135) with videos related to

Sort By:
Pageof 14
Current Opinion in Pulmonary Medicine|July 1, 1996
Low molecular weight heparin for the prevention of deep vein thrombosis following orthopedic surgeryM R Lassen, L C Borris
Ugeskrift for Laeger|December 7, 1992
[Tinzaparin, a low molecular weight heparin]L C Borris, M R Lassen
Orthopedics|May 16, 2014
Managing the risk of thrombosis in the perioperative period in patients undergoing orthopedic and trauma surgery with low-molecular-weight heparin: enoxaparinM R Lassen, L C Borris
Haemostasis|March 1, 1993
Venography in deep venous thrombosis: postoperative screening of patients in prophylaxis studiesL C Borris, M R Lassen
Orthopedics|February 1, 1997
Managing the risk of thrombosis in the perioperative period in patients undergoing orthopedic and trauma surgery with low-molecular-weight heparin: enoxaparinM R Lassen, L C Borris
Drugs|January 1, 1996
Thromboprophylaxis with low molecular weight heparin after major orthopaedic surgery is cost effectiveL C Borris, M R Lassen
Seminars in Thrombosis and Hemostasis|January 1, 1993
Venography used for deep vein thrombosis screening of asymptomatic patients undergoing total hip replacementL C Borris, M R Lassen
Archives of Internal Medicine|June 11, 2003
Duration of prophylaxis against venous thromboembolism with fondaparinux after hip fracture surgery: a multicenter, randomized, placebo-controlled, double-blind studyBengt I Eriksson, Michael R Lassen,
The European Journal of Surgery. Supplement. : = Acta Chirurgica. Supplement|January 1, 1994
Clinical profile of enoxaparin in a high-risk situationM R Lassen, L C Borris
Drug Safety|January 1, 1995
A comparative review of the adverse effect profiles of heparins and heparinoidsL C Borris, M R Lassen
Pageof 14